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Abstract
Background: Gastric cancer is the second leading cause of oncologic death worldwide. One of
the most noteworthy characteristics of this tumor's epidemiology is the marked decline reported
in its incidence and mortality in almost every part of the globe in recent decades. This study sought
to describe gastric cancer mortality time trends in Spain's regions for both sexes.
Methods: Mortality data for the period 1976 through 2005 were obtained from the Spanish
National Statistics Institute. Cases were identified using the International Classification of Diseases
9th and 10th revision (codes 151 and C16, respectively). Crude and standardized mortality rates
were calculated by geographic area, sex, and five-year period. Joinpoint regression analyses were
performed to ascertain whether changes in gastric cancer mortality trends had occurred, and to
estimate the annual percent change by sex and geographic area.
Results: Gastric cancer mortality decreased across the study period, with the downward trend
being most pronounced in women and in certain regions situated in the interior and north of
mainland Spain. Across the study period, there was an overall decrease of 2.90% per annum among
men and 3.65% per annum among women. Generally, regions in which the rate of decline was
sharpest were those that had initially registered the highest rates. However, the rate of decline was
not constant throughout the study period: joinpoint analysis detected a shift in trend for both sexes
in the early 1980s.
Conclusion: Gastric cancer mortality displayed in both sexes a downward trend during the study
period, both nationally and regionally. The different trend in rates in the respective geographic
areas translated as greater regional homogeneity in gastric cancer mortality by the end of the study
period. In contrast, rates in women fell more than did those in men. The increasing differences
between the sexes could indicate that some risk factors may be modifying the sex-specific pattern
of this tumor.
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Background
Gastric cancer (GC) is the second leading cause of onco-
logic death worldwide [1,2], due to its elevated incidence
and lethality; in many countries survival at five years of
diagnosis is under 20% [3]. This cancer, with higher rates
in males and sex ratios generally close to 2, displays wide
geographic variability. In Japan, China and some regions
of Eastern Europe and Latin America (Chile, Ecuador),
rates are almost 20 times higher than those registered in
India, the Philippines, USA or some areas in North and
East Africa [1,2].
One of the most noteworthy characteristics of this tumor's
epidemiology is the marked decrease seen in its incidence
and mortality since the second half of the 20th century:
whereas stomach cancer was the second leading cause of
death due to malignant tumors in the European Commu-
nity in the 1990s [4], it currently ranks fourth after tumors
of lung, breast and colon [2]. In Europe, gastric cancer
incidence and mortality have registered a downward trend
since the 1960s [5,6].
Generally, this downward turn in gastric cancer is attrib-
uted to changes in some risk factors traditionally impli-
cated in its etiology, namely: improvements in the way in
which food is preserved, including the use of refrigeration,
changes in the dietary habits of the population, and the
decline in the prevalence of Helicobacter pylori infection [7-
9]. Yet, as is the case with most tumors, the etiology of gas-
tric cancer has not been entirely elucidated, in that there
are other risk factors referred to in the literature, such as
socio-economic level [10], presence of contaminants in
drinking water [11,12], and certain occupational expo-
sures [13,14].
In Spain, the trend in GC mortality rates in recent years
has been similar to that of other countries in Western
Europe. This tumor is currently the 5th leading cause of
cancer-related death in both sexes, with rates of 12.94 and
5.65 in men and women, respectively [15]. However, as
has also been reported in other European countries, such
as Greece and Italy [16], there are important geographic
differences within Spain. In this sense, some Spanish
regions present mortality rates that are much higher than
the European mean, while others show rates that are
among the lowest in the continent [17,18]. This study
sought to describe GC mortality time trends in Spain and
its constituent regions, for the period 1976 through 2005.
Methods
Mortality data were drawn from individual death entries
furnished by the National Statistics Institute (NSI). We
included all deaths certified as stomach cancer (codes 151
and C16 of the International Classifications of Diseases,
9th and 10th revisions (ICD-9 and ICD-10), respectively)
in the period 1976-2005. As denominators, we used pop-
ulations estimated at July 1 of each year, also provided by
the NSI.
Crude and standardized mortality rates were calculated by
the direct method (standard European population) for
each Autonomous Region (AR), sex and five-year period
(1976-1980,...; 2000-2005).
Trends in mortality rates (national and regional) were cal-
culated by estimating the annual percent change (APC)
and studying possible joinpoints (points at which a
change in trend during the period is observed) in the
trend. For this purpose, crude and standardized rates were
then calculated for each calendar year, again broken down
by AR, sex, and broadly categorized age group (35-64 and
over 64 years).
Joinpoint analysis is known as multiple-phase regression
analysis and is based on a Poisson model that fits the
observed mortality rates [19]. Starting with the model
having the minimum number of joinpoints the program
adds new joinpoints (up to a maximum of three), and
ascertains whether these should or should not be included
in the initial model on the basis of their significance. To
this end it performs hypothesis tests among the different
models, based on a Monte Carlo method [20,21]. The
final model estimates the joinpoints and the APC for each
temporal segment displaying constant trend. Each join-
point indicates a significant change in trend during the
study period.
Results
Table 1 shows the standardized five-yearly mortality rates
for Spain as a whole and for each of the ARs, grouped by
trend pattern registered over the study period and geo-
graphic location. Higher mortality rates were registered at
the beginning of the period, with these being particularly
high in some regions in inland and Northern Spain, with
Castile & León at the head. Across the period analyzed,
mortality decreased in all regions of Spain. This decline
was more pronounced in those areas which initially had
the highest rates, something that translated as greater
regional homogeneity in GC mortality by the end of the
study period. Hence, in the first five-year period, the
observed rates ratio among the regions with highest and
lowest mortality (Castile & León and the Balearic Islands,
respectively) was 2.53 for men and 3.54 for women, while
in the last five-year period these ratios were 1.99 and 2.10,
respectively. Despite the declining trends, central and
Northern Spain continued to be the regions with the high-
est rates in 2005, with Castile & León again at the head. In
terms of gender, mortality was always higher in males,
both nationally and regionally.BMC Cancer 2009, 9:346 http://www.biomedcentral.com/1471-2407/9/346
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Figure 1 depicts the trend of standardized and truncated
rates (ages 35-64 years and 65 years or more). Note
should be taken of the steeper downward trend among
women aged over 65 years. [see Additional file 1] shows
the APC for the entire period and for the last 10 years,
together with the rates for the first and last quinquennia.
Also shown are the inflection points detected and the
trend for each time segment. Across the study period,
there was an overall decrease in the rates of 2.90% per
annum in men and 3.65% per annum in women. Join-
point analysis detected a change in trend in both sexes in
the early 1980s. During the first period, rates fell by 4.58%
per annum in men and 5.24% per annum in women, with
the rate of decline leveling off thereafter.
When the trend was analyzed in the individual ARs
(excluding the autonomous city enclaves of Ceuta and
Melilla), two mortality patterns were discerned (Figure 2).
The first of these included the ARs situated in the interior
and in Northern Spain (Castile & León, Castile-La Man-
Table 1: Gastric cancer mortality in Spain (1976-2005): age-adjusted mortality rates per 100,000 person-years (European standard 
population).
1976-1980 1981-1985 1986-1990 1991-1995 1996-2000 2001-2005
MEN
SPAIN 32.12 25.7 23.00 20.00 17.42 15.14
Inland ARs1 Castile & León 46.98 36.53 31.81 28.40 24.31 20.14
Rioja 34.52 31.68 24.38 21.52 20.28 14.67
Aragon 31.94 26.77 23.60 18.53 15.45 14.10
Castile-La Mancha 37.20 28.69 25.96 20.91 18.11 15.95
Extremadura 40.39 31.01 26.31 21.14 18.72 17.89
Madrid 26.01 19.84 19.50 18.44 16.27 14.07
Northern ARs1 Galicia 37.68 30.11 28.38 24.02 21.22 17.39
Navarre 39.76 29.57 27.01 23.53 18.66 16.13
Asturias 33.50 27.45 23.84 18.97 19.06 15.72
Cantabria 30.77 22.37 21.25 18.26 17.74 14.36
Basque Country 37.03 30.60 27.05 24.85 21.10 17.83
Eastern ARs1 (Levante) Valencia 27.71 22.53 22.25 18.76 17.26 14.50
Catalonia 28.41 23.18 21.01 18.39 15.36 14.31
Murcia 26.16 22.98 18.26 15.14 15.48 13.44
Southern ARs1 Andalusia 29.47 23.96 19.75 16.98 15.16 13.87
Islands Balearic Islands 18.58 15.03 13.44 14.57 13.44 10.10
Canary Islands 21.64 18.97 15.46 14.15 12.41 10.38
Ceuta/Melilla Ceuta 34.26 34.62 23.32 14.63 16.12 14.9
Melilla 27.67 21.07 14.51 10.97 8.10 11.50
WOMEN
SPAIN 16.33 12.76 11.07 9.13 7.50 6.43
Inland ARs1 Castile & León 26.95 19.82 16.18 13.26 10.13 8.85
Rioja 18.80 13.71 11.61 11.95 6.46 8.22
Aragon 18.57 14.23 11.60 9.82 7.81 6.37
Castile-La Mancha 19.98 16.01 12.12 9.76 8.04 6.76
Extremadura 18.66 15.79 12.22 9.85 8.04 5.85
Madrid 12.80 9.94 10.17 8.61 7.15 6.11
Northern ARs1 Galicia 20.08 16.52 14.58 11.63 9.94 8.33
Navarre 19.77 13.00 13.36 9.32 7.82 6.90
Asturias 18.18 13.84 12.44 9.68 7.89 6.54
Cantabria 14.93 11.02 10.09 7.18 6.46 6.19
Basque Country 17.20 13.19 11.90 9.51 7.74 6.64
Eastern ARs1 (Levante) Valencia 14.51 11.57 10.56 8.68 7.15 6.54
Catalonia 14.37 11.37 9.94 8.43 6.85 5.84
Murcia 14.17 10.11 8.87 8.76 7.28 6.46
Southern ARs1 Andalusia 13.25 10.75 8.86 7.04 6.39 5.46
Islands Balearic Islands 7.62 7.48 7.47 7.00 4.65 4.21
Canary Islands 11.80 8.12 6.33 6.45 5.51 4.53
Ceuta/Melilla Ceuta 17.17 11.38 11.71 12.42 6.17 4.60
Melilla 15.81 10.89 10.35 11.93 6.05 6.30
1 ARs: Autonomous Regions.BMC Cancer 2009, 9:346 http://www.biomedcentral.com/1471-2407/9/346
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cha, Extremadura, La Rioja, and Aragon), with the highest
rates at the beginning of the period and the greatest over-
all rate of decline during the initial years studied (APC of
2.7% to 3.6% in males, and 3.4% to 4.4% in women). The
second group included the ARs in Eastern Spain, Andalu-
sia and the Canary and Balearic Islands, with the lowest
rates and, in general, lower rates of decline. The Madrid
Region registered a pattern unlike that of the other ARs in
the center of the country, with its trend being more like
that of Eastern Spain. As reference, figure 3 shows the sit-
uation of Spain's Autonomous Communities.
Finally, it should be noted that the decline in the rates was
greater among females, a phenomenon observed through-
out the period. This larger rate of decline in women (who
started from lower rates) explains the fact that sex-related
differences have become more pronounced in recent
years. Indeed, in some areas this has been compounded
by the slowdown observed in the decrease in male mortal-
ity during the last ten years (e.g. Extremadura, Andalusia
and Catalonia).
Discussion
Our results highlight a decrease in GC mortality in Spain
across the entire study period. This fall proved greatest in
areas which initially had the highest rates (inland areas
lying near the Cantabrian mountains and the central pla-
teau), a phenomenon that has made for greater uniform-
ity among the different regional rates over time. Castile &
León maintain the highest rates, with an especially high
degree of excess mortality in men. Despite having started
from lower rates, women nonetheless registered a greater
decline in mortality rates due to this tumor.
When it comes to interpreting these results, the limita-
tions of mortality data must be borne in mind. To study
cause-specific trends, the best approach would be to com-
bine incidence and mortality data. As there is no informa-
tion on GC incidence countrywide, mortality continues to
be the sole comprehensive source of information in
Spain. In the case of GC, the fact that relative survival at 5
years is low, i.e., 24.9% in Europe and 31.8% in Spain
[22], means that mortality data are a relatively reliable
approximation of incidence rates. However, some authors
suggest that in some countries the decline in mortality
might have been swifter than that of incidence, in some
countries at least [23]. Available incidence data from
regional cancer population registries also suggest that this
might be the case in Spain [24].
A further possible limitation of the data used is linked to
the quality of death registry entries. In Spain, a recent
review indicated that, for GC, mortality statistics are a
valid and useful tool for estimating this tumor's impact
[25]. Nevertheless, there are discontinuities in the coding
which could be responsible for some of the changes
Trend by sex in standardized and truncated rates and cases observed across the period Figure 1
Trend by sex in standardized and truncated rates and cases observed across the period.
Men WomenBMC Cancer 2009, 9:346 http://www.biomedcentral.com/1471-2407/9/346
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observed in trends. The change in coding from ICD-8 to
ICD-9 was introduced around 1980, and could be related
with the change in trend observed for the country in the
early 80s. In addition, the decentralization in the coding
of mortality statistics in this decade led to an increase in
the quality of these data [25], which might be responsible
for some of the shifts in trends, as could be the case of
Madrid. The improvement in the coding of some gyneco-
logical neoplasms (of ovarian or uterine origin), which
have sometimes been erroneously registered as tumors of
other organs of the abdominal cavity such as stomach,
could have had some degree of influence on the sharper
decline in trends among women [25].
To delimit the true causes that have led to the observed
differences in GC trends among ARs is complex. Some fac-
tors, such as the role of H. pylori as a carcinogenic pro-
moter [26], or diet [27,28], which contribute to the
etiopathogeny of GC are widely accepted. In Spain, stud-
ies published on the prevalence of H. pylori infection
report interregional differences ranging from 43% [29] to
69% [30], but the scarcity of data do not enable their
implication in the trend in rates to be assessed. Insofar as
diet is concerned, some risk factors, e.g., intake of nitrates
through consumption of cured and pickled foods [31,32]
or drinking water [33,34], and prevention factors, e.g.,
consumption of fruit and vegetables in particular, have
been recognized. Along with these factors, others have
been described, such as socio-economic differences, a var-
iable that may in turn indicate differences in exposure to
various factors including prevalence of H. pylori infection,
diet, tobacco use, alcohol, or access to the health system,
among others [23].
During the study period, Spain's society underwent major
transformations. Vigorous economic development was
accompanied by important changes in social structure,
with the urban middle classes becoming predominant,
and increases in per capita income and the percentage allo-
cated to public health expenditure [35,36]. All these
Trend in gastric cancer mortality from 1975 to 2005, by area and sex Figure 2
Trend in gastric cancer mortality from 1975 to 2005, by area and sex.
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changes, taken together with a notable improvement in
lifestyles, took place in parallel with the trend plotted by
gastric cancer mortality.
In terms of socio-economic level, uniformity in rates has
been accompanied by a convergence in socioeconomic
levels among the different ARs [37,38]. Even so, if one
examines the economic level of each AR, it will be noted
that among the ARs which had a lower socioeconomic
level in the mid-20th century, some are still registering the
highest GC mortality rates 25-30 years afterwards (Extre-
madura, Castile & León, Castile-La Mancha, and Galicia),
whereas in others (Murcia, Andalusia) the opposite has
occurred. Similarly, areas in which GDP per capita was
higher than the national mean in the 1970s, such as Nav-
arre or La Rioja, register elevated mortality rates.
In general terms, one of the reasons that may account for
the decrease in mortality rates is the change in diet, with a
progressive globalization in food consumption patterns
and greater accessibility to perishable foods [39]. Whereas
Spaniards' food intake was very unequal at the beginning
of the century, being characterized by protein, mineral
and vitamin deficiency [40], the nutritional transition,
initiated with the industrialization process, entailed a
change in the consumption of basic foods and an increase
in foods of animal origin, fruit, and sugars. Homemade
food production thus fell and industrial production rose.
An important element in this change was the introduction
of the first refrigerators in Spain in the early 1950s, though
these were to take some years in finding their way into all
Spanish homes. Little by little, habits tend to become
more uniform, and differences in terms of consumption
of certain foods, such as fruit and vegetables, viewed as
protective against GC by providing compounds with anti-
oxidant properties, tend to disappear [39,41,42].
With respect to H. pylori's role as a carcinogenic promoter,
it has not been possible to measure the impact of H. pylori
eradication treatment on the decrease in GC incidence
[43], yet there is strong evidence to show that administra-
tion of such treatment in certain subgroups of patients
Spanish Autonomous Communities Figure 3
Spanish Autonomous Communities.BMC Cancer 2009, 9:346 http://www.biomedcentral.com/1471-2407/9/346
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prevents the progression of precursor lesions [44]. Sight
should therefore not be lost of the favorable effect that the
introduction and progressive improvement in H. pylori
treatment guidelines, coupled with the generalized use of
antibiotics which took place in the latter half of the 20th
century, may have had on the observed trends.
Along these same lines, the role of probiotics in the pre-
vention and eradication of H. pylori has recently been pro-
posed [45-49]. The population's growing concern with
health has made the so-called "functional foods" fashion-
able (i.e., foods enriched with biologically activated com-
ponents); probiotics constituting up to 65% of the
European functional food market [50]. Specifically, in
Eastern Spain a reduction in the consumption of liquid
milk in favor of enriched dairy products has been
observed [51,52], fundamentally among the higher-level
social classes [53]. This also occurs in the Canary Islands
[54] and Andalusia, where these products have tradition-
ally been less expensive and the habit of consuming such
foods is better established. In contrast, in the North and
North-west regions and in Castile-La Mancha, the con-
sumption of liquid milk still takes precedence.
Another factor that could be implicated in the decline in
mortality is the improvement in drinking-water quality,
linked to the country's economic development. Thus, in
the study period, the population supplied by surface
waters increased, in detriment to the use of subterranean
waters which have a lower power of recovery vis-à-vis the
presence of contaminants [55]. Besides, quality criteria set
by international bodies became more stringent [56],
thereby contributing to the decrease in exposure to physi-
cal or biological chemical contaminants in the Spanish
population [57].
Lastly, stress must again be laid on the differences
between the two sexes observed in the trend. To explain
some of the sex-related differences in GC distribution, the
protective role of estrogenic hormones has been pro-
posed. These differences would not, however, account for
the different behavior observed in the rates of decline,
bearing in mind that when these rates were truncated,
these differences were seen to become even more pro-
nounced in women aged over 65 years. The role that
improvements in coding may have had on this finding,
has already been discussed above. Nevertheless, in view of
the dominant role of environmental factors in the appear-
ance of GC, consideration should be given to the possible
coexistence of other factors of unequal sex-related distri-
bution which might be influencing the two groups differ-
ently. Some authors propose greater self-care among
women, or cite the different effect that physical exercise
may have in both sexes, e.g., a recently published paper
proposes the beneficial role of an increase in physical
activity on reduction in GC risk among women, with no
such effect being found for gastric cancer among males
[58].
Conclusion
In conclusion, gastric cancer displayed a downward trend
throughout the study period, both for Spain overall and
for all the country's constituent regions, across the sexes.
The different trend registered in the Spanish ARs has, how-
ever, translated as greater regional homogeneity in mor-
tality due to this tumor because the fall was steeper in
areas which initially had the highest rates. It is essential
that efforts continue to be directed at ascertaining which
factors are determining the greater rate of decline among
women. Their identification could amount to an impor-
tant advance in the prevention of this tumor.
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